Carl N Kraus Aquestive Therapeutics, Inc. (AQST) insider trading activity

Carl N Kraus is Chief Medical Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 282,475 shares of AQST, which is worth approximately $1.99 Million. The most recent transaction as insider was on Oct 15, 2025, when has been sold 20,272 shares (Common Stock) at a price of $7.0 per share, resulting in proceeds of $141,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 282K

9.92% 3M change

12.24% 12M change

Total Value Held $1.99 Million

Carl N Kraus Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	SELL Open market or private sale	$141,904 $7.0 p/Share	20,272 Reduced 6.7%	282,475 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$21,504 $2.65 p/Share	8,115 Reduced 2.52%	313,566 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	70,000 Added 17.87%	321,681 Common Stock
Aug 09 2024	SELL Payment of exercise price or tax liability	$37,109 $3.43 p/Share	10,819 Reduced 4.12%	251,681 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	112,500 Added 30.0%	262,500 Common Stock
Aug 09 2023	BUY Grant, award, or other acquisition	-	150,000 Added 50.0%	150,000 Common Stock

Also insider at

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

CHIEF MEDICAL OFFICER

CNK

Carl N Kraus

Chief Medical Officer

Exton, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Value

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST

Account